n.a. (DSCI)

0.00
NASDAQ
Prev Close 0.00
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.00 / 0.00
Exchange NASDAQ
Div & Yield N.A. (N.A)
Derma Sciences To Participate In Two Upcoming Investor Conferences In December

Derma Sciences To Participate In Two Upcoming Investor Conferences In December

Derma Sciences, Inc. (Nasdaq: DSCI), a tissue regeneration company focused on advanced wound and burn care, today announced that management will be participating in two upcoming investor conferences.

Derma Sciences To Participate In Canaccord Genuity Medical Technologies And Diagnostics Forum

Derma Sciences To Participate In Canaccord Genuity Medical Technologies And Diagnostics Forum

Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound and burn care, today announced that Edward J.

Derma Sciences Reports Third Quarter Financial Results

Derma Sciences Reports Third Quarter Financial Results

Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound and burn care, today reported financial and operating results for the three and nine months ended September 30, 2014.

Newly Published Final CMS Payments For 2015 Favorably Impact Derma Sciences' TCC-EZ® And AMNIOEXCEL®

Newly Published Final CMS Payments For 2015 Favorably Impact Derma Sciences' TCC-EZ® And AMNIOEXCEL®

Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound and burn care, today announced that on October 31, 2014 the Centers for Medicare and Medicaid Services (CMS) issued the final...

Derma Sciences To Hold Third Quarter Financial Results Conference Call On November 10th

Derma Sciences To Hold Third Quarter Financial Results Conference Call On November 10th

Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound care, announced today that it will hold a conference call on November 10, 2014 to discuss the financial results for the third...

DSCI: Insiders vs. Shorts

DSCI: Insiders vs. Shorts

The most recent short interest data was recently released by the NASDAQ for the 08/15/2014 settlement date, and Derma Sciences Inc. is one of the most shorted stocks of the Russell 3000, based on 15.62 "days to cover" versus the median component at 6.14.

Derma Sciences To Present At Canaccord Genuity 34th Annual Growth Conference On August 14

Derma Sciences To Present At Canaccord Genuity 34th Annual Growth Conference On August 14

Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound care, announced today that Barry Wolfenson, the Company’s Group President, Advanced Wound Care and Pharmaceutical ...

Derma Sciences Reports Second Quarter Financial Results

Derma Sciences Reports Second Quarter Financial Results

Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound and burn care, today reported financial and operating results for the three and six months ended June 30, 2014.

Derma Sciences To Hold Second Quarter Financial Results Conference Call On August 7th

Derma Sciences To Hold Second Quarter Financial Results Conference Call On August 7th

Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound care, announced today that it will hold a conference call on August 7, 2014 to discuss the financial results for the second...

Derma Sciences CEO Discusses Continued Growth Of MEDIHONEY® At Comvita Annual Meeting Of Shareholders

Derma Sciences CEO Discusses Continued Growth Of MEDIHONEY® At Comvita Annual Meeting Of Shareholders

Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound care, announces that Edward J.

Derma Sciences Announces Veterans Administration Adds AMNIOEXCEL® To Its Federal Supply Schedule

Derma Sciences Announces Veterans Administration Adds AMNIOEXCEL® To Its Federal Supply Schedule

Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound care, announces that AMNIOEXCEL®, its novel human amniotic membrane allograft, has been approved by the Veterans...

Derma Sciences, Inc. To Webcast June 17th Analyst Day

Derma Sciences, Inc. To Webcast June 17th Analyst Day

Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound and burn care, announces it will be webcasting its Analyst Day event to be held June 17 in New York City.

Oversold Conditions For Derma Sciences (DSCI)

Oversold Conditions For Derma Sciences (DSCI)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Derma Sciences Reports First Quarter Financial Results

Derma Sciences Reports First Quarter Financial Results

Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound and burn care, today reported financial and operating results for the three months ended March 31, 2014.

Derma Sciences To Present At Sidoti Semiannual Micro-Cap Conference On May 9

Derma Sciences To Present At Sidoti Semiannual Micro-Cap Conference On May 9

Derma Sciences, Inc. (Nasdaq: DSCI), a tissue regeneration company focused on advanced wound care, announced today that Edward J.

Derma Sciences To Hold First Quarter Financial Results Conference Call On May 8th

Derma Sciences To Hold First Quarter Financial Results Conference Call On May 8th

Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound care, announced today that it will hold a conference call on May 8, 2014 to discuss the financial results for the first...

3 Stocks Under $10 Making Big Moves

3 Stocks Under $10 Making Big Moves

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

Derma Sciences Products To Be Featured In 10 Posters And Two Educational Programs At The SAWC Conference; Company Launches New Corporate Branding Campaign

Derma Sciences Products To Be Featured In 10 Posters And Two Educational Programs At The SAWC Conference; Company Launches New Corporate Branding Campaign

Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound care, announces that its products are the subject of 10 poster presentations and abstracts to be featured at the Spring...

Oversold Conditions For Derma Sciences (DSCI)

Oversold Conditions For Derma Sciences (DSCI)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Derma Sciences Reports Fourth Quarter Financial Results, Provides Commercial Update Including Sales Force Expansion And Progress In Launching New Placental-Derived Tissue Products

Derma Sciences Reports Fourth Quarter Financial Results, Provides Commercial Update Including Sales Force Expansion And Progress In Launching New Placental-Derived Tissue Products

Derma Sciences, Inc. (the “Company”) (Nasdaq:DSCI), a tissue regeneration and burn care company focused on advanced wound care, today reported financial and operating results for the three months and year ...

Derma Sciences To Hold Fourth Quarter Financial Results Conference Call On March 14th

Derma Sciences To Hold Fourth Quarter Financial Results Conference Call On March 14th

Derma Sciences, Inc. (the “Company”) (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound care, announced today that it will hold a conference call on March 14, 2014 to discuss the ...

Derma Sciences To Present At The 26th Annual ROTH Conference

Derma Sciences To Present At The 26th Annual ROTH Conference

Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound care, announced today that Edward J.

Derma Sciences Closes $86 Million Underwritten Public Offering Of Common Stock, Including Full Over-Allotment

Derma Sciences Closes $86 Million Underwritten Public Offering Of Common Stock, Including Full Over-Allotment

Derma Sciences, Inc. (the “Company”) (Nasdaq: DSCI), a tissue regeneration company focused on advanced wound care, today announced the closing of an underwritten public offering of 7,500,000 shares of common ...

Derma Sciences Announces Pricing Of Underwritten Public Offering Of Common Stock

Derma Sciences Announces Pricing Of Underwritten Public Offering Of Common Stock

Derma Sciences, Inc. (the “Company”) (Nasdaq: DSCI), a tissue regeneration company focused on advanced wound care, today announced the pricing of an underwritten public offering of 6,521,739 shares of common ...

Derma Sciences Announces Commencement Of Public Offering Of Common Stock

Derma Sciences Announces Commencement Of Public Offering Of Common Stock

Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound care, today announced that it intends to offer shares of its common stock in a public offering.

Derma Sciences Announces Record Revenues For The 2013 Fourth Quarter And Full Year, Introduces 2014 Revenue Guidance, Provides Update On DSC127 Phase 3 Clinical Trials

Derma Sciences Announces Record Revenues For The 2013 Fourth Quarter And Full Year, Introduces 2014 Revenue Guidance, Provides Update On DSC127 Phase 3 Clinical Trials

Derma Sciences, Inc. (Nasdaq:DSCI), a medical device and pharmaceutical company focused on advanced wound care, today announced that total revenue for the full year ended December 31, 2013 is expected to be $79.

Derma Sciences Enters The Skin Substitute Market With Licensing Agreement For Innovative Amniotic Membrane Wound Care Products

Derma Sciences Enters The Skin Substitute Market With Licensing Agreement For Innovative Amniotic Membrane Wound Care Products

Derma Sciences, Inc. (Nasdaq:DSCI), a medical device and pharmaceutical company focused on advanced wound care, announces it has licensed exclusive rights to two novel human placental-derived tissue products for all...

Top Insider Trades: DDR IRWD DSCI ROYE

Top Insider Trades: DDR IRWD DSCI ROYE

The top 10 open-market insider purchases and sales filed at the SEC Monday.

Ratings Changes Today

Upgrades: AEY, ASTE, LAS Downgrades: DSCI Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Derma Sciences To Present At The Oppenheimer & Co. Inc. 24th Annual Healthcare Conference

Derma Sciences To Present At The Oppenheimer & Co. Inc. 24th Annual Healthcare Conference

Derma Sciences, Inc. (Nasdaq:DSCI), a medical device and pharmaceutical company focused on advanced wound care, announced today that Barry Wolfenson, the Company’s Group President, Advanced Wound Care and ...